Related Experiment Videos
European Consensus on Primary Prevention of Coronary Heart Disease
1Central Laboratory Institute for Clinical Chemistry, Westfalische Wilhelms Universitat Münster, West Germany.
Insights
Preventing coronary artery disease (CAD) requires assessing overall cardiovascular risk, not just cholesterol levels. Public health initiatives and individualized care for dyslipidemia are crucial for reducing CAD morbidity and mortality.
Area of Science:
- Cardiology
- Public Health
- Preventive Medicine
Background:
- Coronary artery disease (CAD) remains a significant public health concern in Europe.
- Current guidelines recommend case finding for individuals at risk of CAD.
- Management of elevated lipid levels should integrate overall cardiovascular risk assessment.
Abstract:
The European Consensus on Primary Prevention of Coronary Heart Disease has recommended that providing care for individuals at particular risk for coronary artery disease (CAD) requires case finding through medical examinations in primary care, hospital and employment health examination settings. Decisions concerning management of elevated lipid levels should be based on overall cardiovascular risk. The goal of reducing cholesterol levels through risk reduction can ultimately be accomplished only with the implementation of health education efforts directed toward all age groups and actions by government and supranational agencies, including adequate food labelling to identify fat content, selective taxation to encourage healthful habits and wider availability of exercise facilities. Only measures directed at the overall population can eventually reach the large proportion of individuals at mildly to moderately increased risk for CAD. The European Policy Statement on the Prevention of Coronary Heart Disease recognizes that the question of lipid elevation as a risk factor for CAD involves assessment, not only of cholesterol level alone, but also of triglycerides and the HDL cholesterol lipid fraction. Five specific categories of dyslipidemia have been identified, with individualized screening and treatment strategies advised for each. It is the consensus of the study group panel members that these procedures are both practical and feasible. They begin the necessary long term process to reduce the unacceptably high levels of morbidity and mortality due to CAD throughout the European community.